Scientific Sessions 2024  /  Hot Debates in Heart Failure  /  CRISPR Quagmire: Weighing the Risks of Gene Therapies
Logo

American Heart Association

  9
  0

Final ID:

CRISPR Quagmire: Weighing the Risks of Gene Therapies

  • Mammen, Pradeep  ( University of Kansas Medical Center , Kansas City , Kansas , United States )
  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
    • Author Disclosures:
    Pradeep Mammen: DO NOT have relevant financial relationships | Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:Prothena:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Intellia:Past (completed) ; Consultant:Alnylam:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Hot Debates in Heart Failure

Monday, 11/18/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
CRISPR Clarity: The Time is Now for Gene Editing in Cardiomyopathy

Musunuru Kiran, Olson Eric

Preventing Stage C Begins with Stage B

Patel Kershaw, Ndumele Chiadi

More abstracts from these authors:
Disparities in the Management and Outcomes of Cardiac Amyloidosis in Underrepresented Populations. -how can we bridge the gaps? 10 minutes

Bullock-palmer Renee, Alexander Kevin

Discussant: SCAN-MP

Alexander Kevin

You have to be authorized to contact abstract author. Please, Login
Not Available